3-Hydroxymorphinan
A prodrug , GCC1290K , has been developed on account of 3-HM's poor bioavailability ( 18% ) , and a New Drug Application has been approved for it by the United States Food and Drug Administration . 
<triplet> Food and Drug Administration <subj> United States <obj> applies to jurisdiction